bpc-157 human trial 2025 The Stable Gastric Pentadecapeptide BPC 157 Pleiotropic Beneficial Activity and Its Possible Relations with Neurotransmitter Activity BPC 157: Speed Up Healing
Description
(Anyone classed as seriously deficient should see a doctor and may need B12 injections)
The SYNCHRONIZE-1 trial reported 16.6% mean body weight reduction at 76 weeks
In vitro results are promising, showing induction of degranulation in FcR-expressing cells
it supports natural metabolic processes rather than providing immediate alertness
They work best when combined with antimicrobial treatment, detox strategies, nutrition, lifestyle changes, and interventions targeting the root causes of Lyme and mold symptoms
